Acupuncture in Menopause (AIM) Study: a Pragmatic, Randomized Controlled Trial

Avis et al. · Menopause · 2016

🎯Pragmatic RCT👥n=209High Impact

Evidence Level

STRONG
82/ 100
Quality
4/5
Sample
4/5
Replication
4/5
🎯

OBJECTIVE

Evaluate the effects of acupuncture on hot flashes and quality of life in menopause

👥

WHO

Women aged 45-60 years with ≥4 hot flashes/day

⏱️

DURATION

12 months (6 months treatment + 6 months follow-up)

📍

POINTS

Individualized selection based on TCM diagnosis

🔬 Study Design

209participants
randomization

Acupuncture

n=170

Up to 20 sessions over 6 months

Wait list

n=39

Usual care for 6 months, then acupuncture

⏱️ Duration: 12 months

📊 Results in numbers

0%

Reduction in hot flashes (acupuncture)

0%

Increase in hot flashes (control)

p<0.001

Between-group difference

0%

Maintenance at 12 months

3 sessions

Significant response in

Percentage highlights

36.7%
Reduction in hot flashes (acupuncture)
6.0%
Increase in hot flashes (control)
29.4%
Maintenance at 12 months

📊 Outcome Comparison

Percentage change in hot flashes at 6 months

Acupuncture
-36.7
Control
6
💬 What does this mean for you?

This study showed that acupuncture can significantly reduce menopausal hot flashes by more than one third, with benefits maintained for at least 6 months after the end of treatment. Positive results began to appear as early as the third session, offering a safe alternative to hormone therapy.

📝

Article summary

Plain-language narrative summary

The Acupuncture in Menopause (AIM) Study represents an important milestone in research on alternative treatments for menopausal symptoms, particularly hot flashes. Conducted between 2011 and 2014, this pragmatic randomized clinical trial evaluated 209 women aged 45 to 60 years who experienced at least four hot flashes per day. The pragmatic design of the study was especially valuable because it sought to simulate the real conditions of clinical practice, where acupuncturists can individualize treatments as needed. Participants were randomized into two groups: 170 women received up to 20 acupuncture sessions over six months, while 39 were placed on a wait list (control group) for the first six months, receiving the same treatment afterward.

This approach allowed assessment of both the immediate effects and the durability of acupuncture benefits. The results were impressive and clinically relevant. The group that received acupuncture experienced a 36.7% reduction in hot flash frequency at six months, while the control group had a 6.0% increase. This difference was statistically significant (p<0.001) and clinically important for the women.

A particularly encouraging aspect was that the benefits were maintained at 12 months, with a sustained reduction of 29.4% relative to baseline, demonstrating that the effects of acupuncture persist well beyond the active treatment period. The study also provided valuable insights into optimal dosing. Significant improvement was observed as early as the third week of treatment, corresponding to approximately three sessions. Maximum effect occurred in the seventh week, with a median of eight treatments.

This suggests that women can expect benefits relatively quickly, and that a course of eight to ten sessions may be sufficient to achieve optimal results. Beyond the reduction in hot flashes, the study documented significant improvements in multiple aspects of quality of life. Acupuncture-group participants reported less interference of hot flashes with daily activities, better sleep quality, reduction in anxiety symptoms, fewer somatic symptoms, and better memory/concentration. These secondary benefits are particularly important because hot flashes frequently impact multiple dimensions of female well-being.

The treatment safety was excellent, with only three women reporting mild adverse events: two felt pain during treatment and one experienced a sensation of numbness. This 1.4% adverse-event rate is notably low compared with other interventions for hot flashes. The pragmatic design significantly strengthens the clinical applicability of the results. Unlike many studies that use rigid protocols, this one allowed acupuncturists to adapt points and techniques according to individual clinical presentation, following Traditional Chinese Medicine principles.

This approach better reflects how acupuncture is practiced in the real world. An important limitation is that the study did not include a sham acupuncture group, which precludes determining how much of the benefits are due to specific versus non-specific effects of acupuncture. However, the researchers argue convincingly that pragmatic studies focused on clinical effectiveness are more relevant to patients and health professionals than efficacy studies with artificial controls. Compared with other therapeutic options, acupuncture showed competitive results.

Antidepressants such as escitalopram and venlafaxine, considered viable alternatives to hormone therapy, have shown reductions of approximately 47% in hot flashes in other studies, but with significant rates of adverse events and, in the case of escitalopram, relapse in one third of women after discontinuation. Acupuncture, with a 37% reduction and benefits sustained for six months after the end of treatment, offers an attractive risk-benefit profile. The implications for clinical practice are substantial. The study offers robust evidence that acupuncture can be recommended as a first-line option for women experiencing frequent hot flashes, especially those who prefer to avoid hormone therapy or medications with potential side effects.

The evidence of rapid benefit (three sessions) and lasting effect (at least six months) makes acupuncture an attractive and practical option.

Strengths

  • 1Pragmatic design that reflects real clinical practice
  • 2Prolonged 12-month follow-up assessing durability
  • 3Excellent participant retention (84% at 12 months)
  • 4Comprehensive assessment including quality of life
  • 5Excellent safety profile with few adverse events
⚠️

Limitations

  • 1Absence of a sham acupuncture control group
  • 2Possible reporting bias due to the subjective nature of outcomes
  • 3Difficulty separating specific from non-specific effects
  • 4Control group size smaller than the intervention group
  • 5Results may not be generalizable to other populations
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

The management of hot flashes in menopause constitutes one of the clinical scenarios where acupuncture finds especially fertile ground. Many patients between 45 and 60 years old come to the office with contraindications to hormone therapy — history of breast cancer, thromboembolism, established cardiovascular disease — or simply refuse hormone therapy on informed personal preference. For this profile, the non-hormonal arsenal is essentially restricted to antidepressants with partial efficacy and a non-negligible adverse-effect profile. The AIM Study, with its pragmatic design and 12-month follow-up in 209 women, positions acupuncture as a concrete and sustained alternative: 36.7% reduction in hot flash frequency at the end of active treatment and 29.4% maintenance at 12 months, with only three mild adverse events. These numbers translate into real gains in quality of life — fewer sleep interruptions, less interference with daily activities, and improvement in anxiety —, making this work directly actionable in specialized outpatient practice.

Notable Findings

Two findings deserve particular attention. The first is the speed of response: significant improvement as early as the third session and maximum effect around the seventh week with a median of eight treatments. This is clinically relevant because it allows the physician to set realistic expectations with the patient and define an early assessment point — if there is no perceptible response after four or five sessions, it is worth reconsidering the diagnosis of the energetic pattern or the point strategy. The second finding is durability: the sustained 29.4% reduction at 12 months, six months after the end of active treatment, challenges the narrative that acupuncture produces only transient effects dependent on continuity of sessions. Combined with improvements in sleep, concentration, and somatic symptoms, the study demonstrates that treating hot flashes with acupuncture has systemic repercussions on climacteric well-being — which makes sense within the perspective of Traditional Chinese Medicine, where these symptoms integrate Yin Deficiency patterns with rising Yang.

From My Experience

In my practice at the Pain Center of HC-FMUSP, climacteric women frequently arrive referred by Gynecology precisely when hormone therapy is contraindicated or has been refused. I have observed that the response profile described in the AIM study is quite close to what we routinely see: patients usually report perceptible improvement between the third and fifth sessions, and the effect consolidates around the eighth to tenth session — which aligns well with the article's findings. We typically work with cycles of ten to twelve sessions as initial treatment, followed by monthly maintenance sessions for six months, then bimonthly. The points we most often use include Sanyinjiao (SP-6), Taixi (KI-3), Guanyuan (CV-4), and Zusanli (ST-36), in addition to auricular points for anxiety and insomnia. We frequently combine sleep hygiene counseling and, when there is a pronounced anxious component, articulate with the mental health team. Patients with a Kidney and Liver Yin Deficiency pattern — nocturnal hot flashes, sweating, irritability, reddened tongue — respond consistently better than those with mixed pictures or with a strong Yang Deficiency component. This subgroup detail is what I would most like to see explored in future studies of this scope.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Menopause · 2016

DOI: 10.1097/GME.0000000000000597

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.